Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 10298

1.

The SLC40A1 R178Q mutation is a recurrent cause of hemochromatosis and is associated with a novel pathogenic mechanism.

Ka C, Guellec J, Perpermans X, Kannengiesser C, Ged C, Wuyts W, Cassiman D, de Ledinghen V, Varet B, de Kerguenec C, Oudin C, Gourlaouen I, Lefebvre T, FĂ©rec C, Callebaut I, Le Gac G; French National Network for the Molecular Diagnosis of Inherited Iron Overload Disorders.

Haematologica. 2018 Jul 12. pii: haematol.2018.189845. doi: 10.3324/haematol.2018.189845. [Epub ahead of print]

PMID:
30002125
2.

Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study.

Paalanen K, Rannio K, Rannio T, Asikainen J, Hannonen P, Sokka T.

Clin Exp Rheumatol. 2018 Jun 7. [Epub ahead of print]

PMID:
29998832
3.

Coexistent Alpha-1 Antitrypsin Deficiency and Hereditary Hemochromatosis.

Fiegen AP, Tjarks BJ, Ferguson TJ, Goetz RA, Ladd AE, Tams KC.

S D Med. 2018 Mar;71(3):126-128.

PMID:
29991100
4.

A Rare Case Of a 2 year old Boy With Alagille Syndrome & Type 3 Hereditary Hemochromatosis With TFR2 Mutation.

Khayat AA, Suchi M, Vitola B.

J Pediatr Gastroenterol Nutr. 2018 Jul 6. doi: 10.1097/MPG.0000000000002078. [Epub ahead of print] No abstract available.

PMID:
29985876
5.

Serum Markers of Iron Metabolism in Chronic Liver Diseases.

Radicheva MP, Andonova AN, Milcheva HT, Ivanova NG, Kyuchukova SG, Nikolova MS, Platikanova AS.

Open Access Maced J Med Sci. 2018 Jun 14;6(6):1010-1016. doi: 10.3889/oamjms.2018.251. eCollection 2018 Jun 20.

6.

Phenotyping rare hepcidin deficiency.

Bardou-Jacquet E.

Blood. 2018 Jul 5;132(1):7-8. doi: 10.1182/blood-2018-05-851634. No abstract available.

PMID:
29976780
7.

Transferrin and transferrin receptors update.

Kawabata H.

Free Radic Biol Med. 2018 Jun 30. pii: S0891-5849(18)31160-2. doi: 10.1016/j.freeradbiomed.2018.06.037. [Epub ahead of print]

PMID:
29969719
8.

Hemochromatosis (<i>HFE</i>) Gene Variants are Associated with Increased Mitochondrial DNA Levels during HIV-1 Infection and Antiretroviral Therapy.

Kallianpur AR, Gerschenson M, Hulgan T, Kaur H, Clifford D, Haas D, Murdock DG, McArthur JC, Samuels DC, Simpson D.

AIDS Res Hum Retroviruses. 2018 Jul 3. doi: 10.1089/AID.2018.0025. [Epub ahead of print]

PMID:
29968489
9.

Hemochromatosis: pathophysiology, evaluation and management of hepatic iron overload with a focus on MRI.

Golfeyz S, Lewis S, Weisberg IS.

Expert Rev Gastroenterol Hepatol. 2018 Jul 2. doi: 10.1080/17474124.2018.1496016. [Epub ahead of print]

PMID:
29966105
10.

[Health Risk Evaluation of Organochlorine and Organophosphorous Pesticides in Groundwater in Beijing].

Chen WP, Peng CW, Yang Y, Wu YM.

Huan Jing Ke Xue. 2018 Jan 8;39(1):117-122. doi: 10.13227/j.hjkx.201705130. Chinese.

PMID:
29965672
11.

When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?

Rostoker G.

Semin Dial. 2018 Jun 28. doi: 10.1111/sdi.12732. [Epub ahead of print]

PMID:
29956370
12.

Hepatic Iron Overload following Liver Transplantation from a C282Y/H63D Compound Heterozygous Donor.

Veitsman E, Pras E, Pappo O, Arish A, Eshkenazi R, Feray C, Calderaro J, Azoulay D, Ari ZB.

Case Reports Hepatol. 2018 May 31;2018:4298649. doi: 10.1155/2018/4298649. eCollection 2018.

13.

Fetal Cerebral Hemorrhage due to X-linked GATA1 gene mutation.

Bouchghoul H, Quelin C, Loget P, Encha-Razavi F, Senat MV, Maheut L, Galimand J, Collardeau-Frachon S, Da Costa L, Martinovic J.

Prenat Diagn. 2018 Jun 27. doi: 10.1002/pd.5320. [Epub ahead of print]

PMID:
29949202
14.

Porphyria Cutanea Tarda Presenting with Scleroderma, Ichthyosis, Alopecia, and Vitiligo.

MacGillivray ME, Salopek TG.

Case Rep Dermatol. 2018 May 17;10(2):115-121. doi: 10.1159/000488899. eCollection 2018 May-Aug.

15.

Liver HFE protein content is posttranscriptionally decreased in iron-deficient mice and rats.

Frydlova J, Rogalsky DW, Truksa J, Traeger L, Steinbicker AU, Vokurka M, Krijt J.

Am J Physiol Gastrointest Liver Physiol. 2018 Jun 21. doi: 10.1152/ajpgi.00070.2018. [Epub ahead of print]

PMID:
29927322
16.
17.

Small Molecule Inhibitors of NFkB Reverse Iron Overload and Hepcidin Deregulation in a Zebrafish Model for Hereditary Hemochromatosis Type 3.

Basu S, Jalodia K, Ranjan S, Yeh JJ, Peterson RT, Sachidanandan C.

ACS Chem Biol. 2018 Jun 28. doi: 10.1021/acschembio.8b00317. [Epub ahead of print]

PMID:
29897731
18.

The Japanese experience and pharmacokinetics of antenatal maternal high-dose immunoglobulin treatment as a prophylaxis for neonatal hemochromatosis in siblings.

Okada N, Sasaki A, Saito J, Mitani Y, Yachie A, Takahashi H, Matsubara S, Tenkumo C, Tanaka H, Hata T, Motomura K, Nagasawa J, Wada Y, Sako M, Yamaguchi K, Matsumoto K, Nakamura H, Sago H, Mizuta K.

J Matern Fetal Neonatal Med. 2018 Jun 11:1-131. doi: 10.1080/14767058.2018.1487940. [Epub ahead of print]

PMID:
29890876
19.

The interactions between iron and copper in genetic iron overload syndromes and primary copper toxicoses in Japan.

Tatsumi Y, Kato A, Kato K, Hayashi H.

Hepatol Res. 2018 Jun 7. doi: 10.1111/hepr.13200. [Epub ahead of print] Review.

PMID:
29882374
20.

Cardiac Hemochromatosis Treated With Prolonged Extracorporeal Membrane Oxygenation Support and Chelation Therapy.

Lee JA, Tchantchaleishvili V, Vidula H.

Artif Organs. 2018 May;42(5):575-576. doi: 10.1111/aor.13076. No abstract available.

PMID:
29878536

Supplemental Content

Loading ...
Support Center